DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
DALY - 1 weren’t - 1 ” - 1 Ziyad Al - 1 Aly - 1 “ That’s - 1 Dr - 1 Sanjay Gupta - 1
Top related locs:
VA Поти
Top related orgs:
Louis Health Care - 2 CNN — - 1 Institute for Health Metrics - 1 Veterans Affairs - 1 Nature - 1 CNN - 1 CNN Health - 1 The New York Times Fair Health - 1

Search resuls for: "Louis Health Care"


5 mentions found


☆ Long Covid symptoms create a greater burden of disability than heart disease or cancer, new study shows
  + stars: | 2023-08-21 | by ( Brenda Goodman | ) edition.cnn.com   time to read: +6 min
These health problems include heart problems, blood clots, diabetes, neurologic complications, fatigue and difficulties with mental health and have come to be known collectively as long Covid. That means long Covid creates a higher burden of disability than either heart disease or cancer, which cause about 52 and 50 DALYs for every 1,000 Americans, respectively, according to the Institute for Health Metrics and Evaluation’s Global Burden of Disease study. Studies have since shown that vaccination and early treatment can help curb long covid risk. That may have resulted in some people being included in the control group when they should have been in the infection group. “Our findings highlight the substantial cumulative burden of health loss due to long Covid, and emphasize the ongoing need for health care for those faced with long Covid,” said Al-Aly.
Persons: DALY, weren’t, ”, Ziyad Al, Aly, “ That’s, Dr, Sanjay Gupta, Al Organizations: CNN —, Institute for Health Metrics, Veterans Affairs, Louis Health Care, Nature, CNN, CNN Health
☆ Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
  + stars: | 2023-02-27 | by ( Rocky Swift | ) www.reuters.com   time to read: +3 min
Xocova, a protease inhibitor like the COVID treatments developed by Pfizer Inc (PFE.N) and Merck & Co (MRK.N), was granted emergency approval by Japanese regulators in November, making it the nation's first domestically produced oral treatment for COVID. "If you kill the virus fast enough and sharp enough, the lower the probability of long COVID. According to one study by the Veterans Affairs St. Louis Health Care System, Pfizer's antiviral drug Paxlovid cuts the risk of developing many long COVID symptoms. Shionogi is hoping for Xocova sales of around $1 billion to $1.5 billion this year. "I have no regrets," Teshirogi said, adding that expectations among shareholders and the public had demanded that Shionogi devote its resources to fighting COVID.
☆ Long Covid: Paxlovid reduces risk of long Covid, Veterans Affairs study finds
  + stars: | 2022-11-06 | by ( Jamie Gumbrecht | ) edition.cnn.com   time to read: +4 min
CNN —Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a new study by researchers at the US Department of Veterans Affairs. That corresponded to 2.3 fewer cases of long Covid conditions per 100 people three months after their diagnosis. In the analysis, there wasn’t a statistically significant link between taking Paxlovid and risk of two long Covid conditions: cough and new diabetes diagnosis. The analysis captured Paxlovid use only through the VA system and considered only 12 long Covid conditions, although many people with long Covid describe a wide variety of symptoms. The National Institutes of Health said last month it would launch a study of Paxlovid as a treatment for patients already experiencing long Covid.
☆ COVID raises risk of long-term brain injury, large U.S. study finds
  + stars: | 2022-09-22 | by ( Julie Steenhuysen | ) www.reuters.com   time to read: +3 min
The year-long study, published in Nature Medicine, assessed brain health across 44 different disorders using medical records without patient identifiers from millions of U.S. veterans. Brain and other neurological disorders occurred in 7% more of those who had been infected with COVID compared with a similar group of veterans who had never been infected. That translates into roughly 6.6 million Americans who had brain impairments linked with their COVID infections, the team said. Compared with the control groups, people infected with COVID had a 77% higher risk of developing memory problems. Register now for FREE unlimited access to Reuters.com RegisterReporting by Julie Steenhuysen Editing by Bill BerkrotOur Standards: The Thomson Reuters Trust Principles.
☆ Ученые выяснили, какие проблемы со здоровьем возникают у переболевших COVID-19
  + stars: | 2021-06-16 | by ( Mld Media Srl | ) noi.md   time to read: +1 min
Анализ записей медицинского страхования около двух миллионов пациентов с коронавирусом выявил новые проблемы со здоровьем почти у четверти, в том числе у тех, кто переболел легко или бессимптомно. Наиболее частыми новыми проблемами со здоровьем были боли в нервах и мышцах, затрудненное дыхание, высокое содержание холестерина, недомогание и утомляемость, а также высокое кровяное давление. Некоторые пациенты жаловались на проблемы с кишечником, мигрени, кожные заболевания, сердечные аномалии, нарушения сна, тревогу и депрессию. Поти половина госпитализированных с COVID-19 впоследствии испытали проблемы со здоровьем. Ранее ученые из Йельского университета выяснили, что простуда может защитить человека от коронавируса.
Persons: Зияд АльАли Organizations: The New York Times Fair Health, Louis Health Care, Йельский университет Locations: VA, Поти
0 next >>
Total: 5